Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Sends New Flu Virus Strains To Four Flu Vaccine Makers

This article was originally published in PharmAsia News

Executive Summary

Japan National Infectious Disease Institute sent two H1N1 flu virus strains to four Japanese flu vaccine makers. The Ministry of Health, Labor and Welfare disclosed that the two strains were from Australia's Commonwealth Serum Laboratories and New York Medical College. The target production for the new flu vaccine is July. The four makers are the Chemo-Sero-Therapeutic Research Institute, Denka Seiken, the Research Foundation for Microbial Disease of Osaka University and Kitazato Institute. (Click here for more - Japanese language

Japan National Infectious Disease Institute sent two H1N1 flu virus strains to four Japanese flu vaccine makers. The Ministry of Health, Labor and Welfare disclosed that the two strains were from Australia's Commonwealth Serum Laboratories and New York Medical College. The target production for the new flu vaccine is July. The four makers are the Chemo-Sero-Therapeutic Research Institute, Denka Seiken, the Research Foundation for Microbial Disease of Osaka University and Kitazato Institute. (Click here for more - Japanese language)

"Vaccine Makers Receives Flu Virus Strains" - CB News (6/8/09)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel